Todd Watanabe
Director, Reporting Person's title: President and Chief Executive Officer · 3 filings · Latest: May 4, 2026
Arcutis Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARQT | Watanabe Todd Franklin | — | Mar 3, 2025 | Proposed Sale | $13.03 | 20,880 | $272.1K | — | |
ARQT | Watanabe Todd Franklin | — | Feb 3, 2025 | Proposed Sale | $12.70 | 19,301 | $245.1K | — | |
ARQT | Watanabe Todd Franklin | — | Dec 20, 2024 | Proposed Sale | $15.17 | 15,000 | $227.6K | — | |
ARQT | Watanabe Todd Franklin | — | Nov 4, 2024 | Proposed Sale | $8.68 | 13,871 | $120.5K | — |
← Previous
Page 2 of 2